CD7 CAR-T cells (allogeneic)

CD7-targeted chimeric antigen receptor T-cell therapy

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD7 CAR-T cells (allogeneic), covering 2026-03-04 to 2026-03-04. Get the full timeline:

Most recent: Clinical Trial Update: Novel Unedited Allo Cell Therapy For High Risk T-Cell Malignancies Using CD7-Specific Car T Cells [Phase 1]